在一个地区性男性新冠康复者血浆捐献者群体中，HLA抗体率并未升高。 - Suppr

Suppr

超能文献

HLA Antibody Rates Are Not Increased in a Regional Group of Male COVID-19 Convalescent Plasma Donors.

作者信息

Juskewitch Justin E, Senefeld Jonathon W, Johnson Patrick W, Mills John R, Joyner Michael J, Gandhi Manish J

机构信息

Mayo Clinic, Rochester, MN.

出版信息

Mayo Clin Proc. 2021 Oct;96(10):2727-2728. doi: 10.1016/j.mayocp.2021.08.004. Epub 2021 Aug 20.

DOI:10.1016/j.mayocp.2021.08.004

PMID:34607639

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8376709/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e009/8376709/b85ab087adbc/gr1_lrg.jpg

相似文献

HLA Antibody Rates Are Not Increased in a Regional Group of Male COVID-19 Convalescent Plasma Donors.

Mayo Clin Proc. 2021 Oct;96(10):2727-2728. doi: 10.1016/j.mayocp.2021.08.004. Epub 2021 Aug 20.

COVID-19 does not impact HLA antibody profile in a series of waitlisted renal transplant candidates.

Hum Immunol. 2021 Aug;82(8):568-573. doi: 10.1016/j.humimm.2021.04.002. Epub 2021 Apr 17.

SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects.

Clin Microbiol Infect. 2021 Sep;27(9):1349.e1-1349.e6. doi: 10.1016/j.cmi.2021.05.008. Epub 2021 May 8.

Anti-HLA and anti-SARS-CoV-2 antibodies in kidney transplant recipients with COVID-19.

Transpl Int. 2021 Mar;34(3):596-599. doi: 10.1111/tri.13829. Epub 2021 Feb 26.

Characterization of antibody responses to SARS-CoV-2 in convalescent COVID-19 patients.

J Med Virol. 2021 Apr;93(4):2227-2233. doi: 10.1002/jmv.26646. Epub 2020 Nov 10.

Seroreactivity with COVID-19 antibody testing in CCP donors presenting without a SARS-CoV-2 diagnostic test.

Transfusion. 2021 Jan;61(1):330-331. doi: 10.1111/trf.16146. Epub 2020 Nov 2.

Seroprevalence of ancestral and Beta SARS-CoV-2 antibodies in Malagasy blood donors.

Lancet Glob Health. 2021 Oct;9(10):e1363-e1364. doi: 10.1016/S2214-109X(21)00361-2.

Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients.

J Clin Microbiol. 2020 Nov 18;58(12). doi: 10.1128/JCM.02005-20.

Efficient Identification of High-Titer Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Plasma Samples by Pooling Method.

Arch Pathol Lab Med. 2021 Oct 1;145(10):1221-1227. doi: 10.5858/arpa.2021-0215-SA.

Convalescent Whole Blood Donors Screening Strategies for Providing Efficient and Safe COVID-19 Survivors' Plasma and Other Blood Components.

Isr Med Assoc J. 2021 Jan;23(1):7-10.

引用本文的文献

Impact of COVID-19 pandemic on transplant laboratories: How to mitigate?

Heliyon. 2024 Feb 15;10(4):e26419. doi: 10.1016/j.heliyon.2024.e26419. eCollection 2024 Feb 29.

HLA Sensitization in the Era of COVID-19: Single-Center Experience.

Transplant Proc. 2022 Dec;54(10):2658-2662. doi: 10.1016/j.transproceed.2022.10.024. Epub 2022 Oct 7.

Screening for antibodies to HLA class I in apheresis donors following Covid-19 or SARS-CoV-2 vaccination.

Transfus Apher Sci. 2022 Oct;61(5):103567. doi: 10.1016/j.transci.2022.103567. Epub 2022 Aug 30.

本文引用的文献

Safety of Convalescent Plasma Transfusion.

Mayo Clin Proc. 2021 May;96(5):1368-1369. doi: 10.1016/j.mayocp.2021.03.024.

Elevated Rate of HLA Antibodies in Male COVID-19 Convalescent Plasma Donors: A Risk Factor for Transfusion-Related Acute Lung Injury.

Mayo Clin Proc. 2021 Feb;96(2):500-502. doi: 10.1016/j.mayocp.2020.11.007. Epub 2020 Nov 23.

Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients.

Mayo Clin Proc. 2020 Sep;95(9):1888-1897. doi: 10.1016/j.mayocp.2020.06.028. Epub 2020 Jul 19.

Establishing assay cutoffs for HLA antibody screening of apheresis donors.

Transfusion. 2011 Oct;51(10):2092-101. doi: 10.1111/j.1537-2995.2010.03048.x. Epub 2011 Feb 18.

Diagnostic and pathogenetic considerations in transfusion-related acute lung injury.

Transfusion. 1985 Nov-Dec;25(6):573-7. doi: 10.1046/j.1537-2995.1985.25686071434.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

HLA Antibody Rates Are Not Increased in a Regional Group of Male COVID-19 Convalescent Plasma Donors.

作者信息

Juskewitch Justin E, Senefeld Jonathon W, Johnson Patrick W, Mills John R, Joyner Michael J, Gandhi Manish J

机构信息

Mayo Clinic, Rochester, MN.

出版信息

Mayo Clin Proc. 2021 Oct;96(10):2727-2728. doi: 10.1016/j.mayocp.2021.08.004. Epub 2021 Aug 20.

DOI:10.1016/j.mayocp.2021.08.004

PMID:34607639

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8376709/

Abstract

摘要

相似文献

HLA Antibody Rates Are Not Increased in a Regional Group of Male COVID-19 Convalescent Plasma Donors.

Mayo Clin Proc. 2021 Oct;96(10):2727-2728. doi: 10.1016/j.mayocp.2021.08.004. Epub 2021 Aug 20.

COVID-19 does not impact HLA antibody profile in a series of waitlisted renal transplant candidates.

Hum Immunol. 2021 Aug;82(8):568-573. doi: 10.1016/j.humimm.2021.04.002. Epub 2021 Apr 17.

SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects.

Clin Microbiol Infect. 2021 Sep;27(9):1349.e1-1349.e6. doi: 10.1016/j.cmi.2021.05.008. Epub 2021 May 8.

Anti-HLA and anti-SARS-CoV-2 antibodies in kidney transplant recipients with COVID-19.

Transpl Int. 2021 Mar;34(3):596-599. doi: 10.1111/tri.13829. Epub 2021 Feb 26.

Characterization of antibody responses to SARS-CoV-2 in convalescent COVID-19 patients.

J Med Virol. 2021 Apr;93(4):2227-2233. doi: 10.1002/jmv.26646. Epub 2020 Nov 10.

Seroreactivity with COVID-19 antibody testing in CCP donors presenting without a SARS-CoV-2 diagnostic test.

Transfusion. 2021 Jan;61(1):330-331. doi: 10.1111/trf.16146. Epub 2020 Nov 2.

Seroprevalence of ancestral and Beta SARS-CoV-2 antibodies in Malagasy blood donors.

Lancet Glob Health. 2021 Oct;9(10):e1363-e1364. doi: 10.1016/S2214-109X(21)00361-2.

Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients.

J Clin Microbiol. 2020 Nov 18;58(12). doi: 10.1128/JCM.02005-20.

Efficient Identification of High-Titer Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Plasma Samples by Pooling Method.

Arch Pathol Lab Med. 2021 Oct 1;145(10):1221-1227. doi: 10.5858/arpa.2021-0215-SA.

Convalescent Whole Blood Donors Screening Strategies for Providing Efficient and Safe COVID-19 Survivors' Plasma and Other Blood Components.

Isr Med Assoc J. 2021 Jan;23(1):7-10.

引用本文的文献

Impact of COVID-19 pandemic on transplant laboratories: How to mitigate?

Heliyon. 2024 Feb 15;10(4):e26419. doi: 10.1016/j.heliyon.2024.e26419. eCollection 2024 Feb 29.

HLA Sensitization in the Era of COVID-19: Single-Center Experience.

Transplant Proc. 2022 Dec;54(10):2658-2662. doi: 10.1016/j.transproceed.2022.10.024. Epub 2022 Oct 7.

Screening for antibodies to HLA class I in apheresis donors following Covid-19 or SARS-CoV-2 vaccination.

Transfus Apher Sci. 2022 Oct;61(5):103567. doi: 10.1016/j.transci.2022.103567. Epub 2022 Aug 30.

本文引用的文献

Safety of Convalescent Plasma Transfusion.

Mayo Clin Proc. 2021 May;96(5):1368-1369. doi: 10.1016/j.mayocp.2021.03.024.

Elevated Rate of HLA Antibodies in Male COVID-19 Convalescent Plasma Donors: A Risk Factor for Transfusion-Related Acute Lung Injury.

Mayo Clin Proc. 2021 Feb;96(2):500-502. doi: 10.1016/j.mayocp.2020.11.007. Epub 2020 Nov 23.

Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients.

Mayo Clin Proc. 2020 Sep;95(9):1888-1897. doi: 10.1016/j.mayocp.2020.06.028. Epub 2020 Jul 19.

Establishing assay cutoffs for HLA antibody screening of apheresis donors.

Transfusion. 2011 Oct;51(10):2092-101. doi: 10.1111/j.1537-2995.2010.03048.x. Epub 2011 Feb 18.

Diagnostic and pathogenetic considerations in transfusion-related acute lung injury.

Transfusion. 1985 Nov-Dec;25(6):573-7. doi: 10.1046/j.1537-2995.1985.25686071434.x.